Table 2.
Mechanisms of NETs Formation in the Context of Cancer
| Mouse model | Detected NETs marker | NETs Formation Mechanism | Reference |
|---|---|---|---|
| Lewis lung carcinoma; Breast carcinoma; CML |
WB/IF: H3Cit; IF: DNA Plasma DNA Count; FACS: H3Cit+ Neutrophils |
Cancer cell-derived G-CSF | [41] |
| Melonoma; Lewis lung carcinoma | WB/IF: H3Cit; IF: DNA | Cancer cell-derived G-CSF | [42] |
| Colorectal cancer liver metastasis | IF: MPO+ /H3Cit+/extracellular DNA+ | Tumor-derived IL-8 | [43] |
| Gall bladder cancer | IF: NE+ /H3Cit+/extracellular DNA+ | Cancer cell-derived IL-8 | [44] |
|
Lewis lung carcinoma; Breast carcinoma; Colon carcinoma |
IF: H3Cit+/extracellular DNA+ | Cancer cell-derived CXCR1 and CXCR2 ligands | [45] |
| Lung metastasis of breast cancer | IF: MPO+ /H3Cit+/extracellular DNA+ | Cancer cell-derived Cathepsin C | [46] |
|
melanoma Pancreatic adenocarcinoma Lung adenocarcinoma |
IF: MPO+ /H3Cit+/extracellular DNA+ | Stroma-derived Amyloid β | [47] |
WB Western Blot, IF Immunofluorescence, H3Cit citrullinated histone H3, MPO myeloperoxidase, NE neutrophil elastase, CXCR CXC Chemokine Receptor